Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE NON-CONTROLLING INTERESTS AND STOCKHOLDERS??? EQUITY

v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE NON-CONTROLLING INTERESTS AND STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Non-controlling Interests (“NCI”)
Redeemable non-controlling interests, beginning balance at Dec. 31, 2022 $ 46,623                  
Redeemable Non-controlling Interests (“RNCI”)                    
Distributions to RNCI (494)                  
Accretion of tax equity financing fees 81                  
Investment fund call option exercise 195                  
Net income (loss) 870                  
Redeemable non-controlling interests, ending balance at Sep. 30, 2023 47,275                  
Beginning balance (in shares) at Dec. 31, 2022       33,948,362 18,000,000          
Treasury stock, beginning balance (in shares) at Dec. 31, 2022                 2,101,795  
Beginning balance at Dec. 31, 2022 873,031     $ 3 $ 2 $ 306,314 $ 533,549 $ (4,051) $ (11,788) $ 49,002
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options & share sales to cover taxes, net (in shares)       238,750            
Exercise of stock options & share sales to cover taxes, net 2,367         2,367        
Stock-based compensation expense 12,318         12,318        
Employee stock purchase plan (in shares)       24,833            
Employee stock purchase plan 1,017         1,017        
Restricted stock units released (in shares)       22,601            
Unrealized (loss) gain from interest rate hedges, net of tax 716             716    
Foreign currency translation adjustment (425)             (400)   (25)
Accretion of tax equity financing fees (81)           (81)      
Investment fund call option exercise (195)         (195)        
Contributions from NCI 957                 957
Distributions to NCI (20,521)                 (20,521)
Net income (loss) 29,942           28,735     1,207
Ending balance (in shares) at Sep. 30, 2023       34,234,546 18,000,000          
Treasury stock, ending balance (in shares) at Sep. 30, 2023                 2,101,795  
Ending balance at Sep. 30, 2023 899,126     $ 3 $ 2 321,821 562,203 (3,735) $ (11,788) 30,620
Redeemable non-controlling interests, beginning balance at Jun. 30, 2023 47,994                  
Redeemable Non-controlling Interests (“RNCI”)                    
Distributions to RNCI (159)                  
Accretion of tax equity financing fees 26                  
Net income (loss) (586)                  
Redeemable non-controlling interests, ending balance at Sep. 30, 2023 47,275                  
Beginning balance (in shares) at Jun. 30, 2023       34,200,610 18,000,000          
Treasury stock, beginning balance (in shares) at Jun. 30, 2023                 2,101,795  
Beginning balance at Jun. 30, 2023 873,983     $ 3 $ 2 317,228 540,964 (2,884) $ (11,788) 30,458
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options & share sales to cover taxes, net (in shares)       22,150            
Exercise of stock options & share sales to cover taxes, net 274         274        
Stock-based compensation expense 4,319         4,319        
Restricted stock units released (in shares)       11,786            
Unrealized (loss) gain from interest rate hedges, net of tax 764             764    
Foreign currency translation adjustment (1,651)             (1,615)   (36)
Accretion of tax equity financing fees (26)           (26)      
Contributions from NCI 35                 35
Net income (loss) 21,428           21,265     163
Ending balance (in shares) at Sep. 30, 2023       34,234,546 18,000,000          
Treasury stock, ending balance (in shares) at Sep. 30, 2023                 2,101,795  
Ending balance at Sep. 30, 2023 899,126     $ 3 $ 2 321,821 562,203 (3,735) $ (11,788) 30,620
Redeemable non-controlling interests, beginning balance at Dec. 31, 2023 46,865                  
Redeemable Non-controlling Interests (“RNCI”)                    
Distributions to RNCI (418)                  
Accretion of tax equity financing fees 80                  
Net income (loss) (3,766)                  
Redeemable non-controlling interests, ending balance at Sep. 30, 2024 $ 42,761                  
Beginning balance (in shares) at Dec. 31, 2023   34,277,195 18,000,000 34,277,195 18,000,000          
Treasury stock, beginning balance (in shares) at Dec. 31, 2023 2,101,795               2,101,795  
Beginning balance at Dec. 31, 2023 $ 925,886     $ 3 $ 2 320,892 595,911 (3,045) $ (11,788) 23,911
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options & share sales to cover taxes, net (in shares)       70,089            
Exercise of stock options & share sales to cover taxes, net 909         909        
Stock-based compensation expense 10,368         10,368        
Employee stock purchase plan (in shares)       32,841            
Employee stock purchase plan 990         990        
Restricted stock units released (in shares)       62,626         40  
Unrealized (loss) gain from interest rate hedges, net of tax (446)             (446)    
Foreign currency translation adjustment 652             688   (36)
Accretion of tax equity financing fees (80)           (80)      
Contributions from NCI 33,789         3,040       30,749
Distributions to NCI (1,367)                 (1,367)
Purchase of shares from NCI (23,760)         226       (23,986)
Net income (loss) $ 19,796           19,672     124
Ending balance (in shares) at Sep. 30, 2024   34,442,751 18,000,000 34,442,751 18,000,000          
Treasury stock, ending balance (in shares) at Sep. 30, 2024 2,101,835               2,101,835  
Ending balance at Sep. 30, 2024 $ 966,737     $ 3 $ 2 336,425 615,503 (2,803) $ (11,788) 29,395
Redeemable non-controlling interests, beginning balance at Jun. 30, 2024 43,777                  
Redeemable Non-controlling Interests (“RNCI”)                    
Distributions to RNCI (130)                  
Accretion of tax equity financing fees 26                  
Net income (loss) (912)                  
Redeemable non-controlling interests, ending balance at Sep. 30, 2024 42,761                  
Beginning balance (in shares) at Jun. 30, 2024       34,402,515 18,000,000          
Treasury stock, beginning balance (in shares) at Jun. 30, 2024                 2,101,795  
Beginning balance at Jun. 30, 2024 941,192     $ 3 $ 2 332,356 597,930 (3,800) $ (11,788) 26,489
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options & share sales to cover taxes, net (in shares)       7,500            
Exercise of stock options & share sales to cover taxes, net 405         405        
Stock-based compensation expense 3,664         3,664        
Restricted stock units released (in shares)       32,736         40  
Unrealized (loss) gain from interest rate hedges, net of tax (1,060)             (1,060)    
Foreign currency translation adjustment 2,003             2,057   (54)
Accretion of tax equity financing fees (26)           (26)      
Contributions from NCI 2,997                 2,997
Distributions to NCI (364)                 (364)
Net income (loss) $ 17,926           17,599     327
Ending balance (in shares) at Sep. 30, 2024   34,442,751 18,000,000 34,442,751 18,000,000          
Treasury stock, ending balance (in shares) at Sep. 30, 2024 2,101,835               2,101,835  
Ending balance at Sep. 30, 2024 $ 966,737     $ 3 $ 2 $ 336,425 $ 615,503 $ (2,803) $ (11,788) $ 29,395